Publisher
Springer Science and Business Media LLC
Subject
Management of Technology and Innovation,Health Policy,Issues, ethics and legal aspects,Health(social science)
Reference118 articles.
1. Ahmed, E., & Hens, K. (2020). Cognitive enhancement: Toward a rational public consensus. AJOB Neuroscience, 11(4), 263–265. https://doi.org/10.1080/21507740.2020.1830871
2. Aikins, R., Zhang, X., & McCabe, S. E. (2017). Academic doping: Institutional policies regarding nonmedical use of prescription stimulants in U.S. higher education. Journal of Academic Ethics, 15(3), 229–243. https://doi.org/10.1007/s10805-017-9291-0
3. Allen, M. D., & Fong, A. K. (2008). Clinical application of standardized cognitive assessment using fMRI II. Verbal fluency. Behavioural Neurology, 20(3), 141–152.
4. American Medical Association (2016). AMA confronts the rise of nootropics.
5. Ansari, D., Konig, J., Leask, M., & Tokuhama-Espinosa, T. (2017). Developmental cognitive neuroscience: Implications for teachers’ pedagogical knowledge. In S. Guerriero (Ed.), Pedagogical knowledge and the changing nature of the teaching profession (pp. 195–222). OECD Publishing.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献